期刊文献+

高危HPV感染及hTERC基因在宫颈癌发生发展中的相关性 被引量:4

Correlation of High Risk-HPV Infection and the Human Telomerase Gene in Cervical Cancer
原文传递
导出
摘要 目的:探讨高危人乳头瘤病毒及人类染色体端粒酶基因(hTERC)在宫颈癌发生发展中的关系。方法:2010年10月至2011年05月就诊于哈尔滨医科大学附属第一医院妇科患者445例,采用表面等离子体谐振法(SPR)及荧光原位杂交法(FISH)分别检测高危HPV和hTERC的表达情况,对任一结果阳性者行阴道镜下宫颈活检和病理学检查,其中炎症对照组45例,CIN组33例及宫颈癌组6例。结果:单一型HPV29例,多重型26例,最常见为HPV16型合并的二型感染(17例)。在炎症组,CINⅠ组,CINⅡ组、CINⅢ组及宫颈癌组中多重高危HPV比率为17.78%、28.57%、44.44%、50.00%、66.67%,与炎症对照组比较其他组均有统计学意义(P<0.05)。hTERC基因在各组中的阳性表达率分别为2.22%、14.29%、61.11%、75.00%及100%。CIN组及宫颈癌的hTERC基因表达与炎症组比较差异均有统计学意义(P均<0.01),其中CINⅡ及以上各组差异明显。多重HPV感染与hTERC表达呈中等正相关(r=0.462,P<0.01)。结论:随着宫颈病理类型分级升高,HPV感染及hTERC基因表达率升高,hTERC基因在宫颈癌发生发展中起重要作用;高危HPV感染与hTERC基因的异常扩增关系密切,提示二者可能存在因果关系。 Objective: To investigate the relationship of HR-HPV infection and the Human Telomerase Gene(hTERC) in the generation and progression of cervical cancer.Methods: The cervical samples of 445 women visited the First Clinical College of Harbin Medical University from October 2010 to May 2011 underwent the test for HR-HPV with SPR method.hTERC expression was detected by FISH.Then the sample with any positive result underwent colposcopic indicated biopsy and pathological diagnosis.Results: The pathological results showed that 45 of inflammation,33of CIN and 6 Cervical cancer.Among the 445 cases,there were 29 of single HR-HPV infection and 26 of multi-infection,including HPV 16/X double infection(17/26).The rate of multiple HR-HPV infection was 66.67% in cervical cancer group,28.57% in CINⅠgroup,44.44% in CINⅡgroup,50.00% in CINⅢ group and 30.56% in inflammation group,respectively.The infection rate of any group was higher than that in inflammation group(all P0.05).The positive amplification rate of hTERC in inflammation group was 2.22%,while it was 14.29% for CINⅠ,61.11% for CINⅡ,75.00% for CINⅢand the cervical 100%for cancer,which showed a significant difference(all P0.01),evidently in CINⅡand CINⅡ+.The multiple HR-HPV infection was middle-positive correlated to hTERC expression(r=0.462,P0.01).Conclusions: As the development of cervical cancer,the HR-HPV Infection and hTERC expression increased and hTERC gene may play an important part in the pathogenesis of cervical cancer.The HR-HPV infection may be a positive-stimulated fact of hTERC gene.
出处 《现代生物医学进展》 CAS 2012年第25期4826-4828,4832,共4页 Progress in Modern Biomedicine
基金 中华医学会分子生物学临床应用研究专项资金(CAMB022010)
关键词 HTERC基因 人乳头瘤状病毒 多重高危型HPV 宫颈癌 hTERC gene SPR HR-HPVinfection Cervical cancer
  • 相关文献

参考文献20

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics [J]. CACancer J Clin, 2005, 55: 74-108.
  • 2N W J Bulkmans, J Berkhof, L Rozendaal, et al. Human papillo-mavirus DNA testing for the detection of cervical intraepithelial neo-plasia grade 3 and cancer: 5-year follow-up of a randomised con-trolled implementation trial[J]. Lancet, 2007,370: 1764-1772.
  • 3rstin HH, Viktor J, Philip EC, et al. Detection of Genomic Amplifi-cation of the Human Telomerase Gene (TERC) in Cytologic Speci-mens as a Genetic Test for the Diagnosis of Cervical Dysplasia [J].an Journal of Pathology, 2003,163:1406-1416.
  • 4Ying Li, Wen-Jie Zeng, Feng Ye, et al. Application of hTERC in thin-prep samples with mild cytologic abnormality and HR-HPV positive卩].Gynecologic Oncology, 2011,120: 73-83.
  • 5姚军,李曼,钟萍,朱春江,曾思恩.HPV多重感染与宫颈病变的相关性研究[J].华中科技大学学报(医学版),2010,39(5):705-707. 被引量:23
  • 6Gilbert G,Donders G, Gabrovska M, et al. Knowledge of cervix can-cer,human papilloma virus(HPV)and HPV vaccination at the momentof introduction of the vaccine in women in Belgium[J].Arch GynecolObstet, 2008,277(4): 291-298.
  • 7von Knebel Doeberitz M. New markers for cervical dysplasia to visu-alise the genomic chaos created by aberrant oncogenic papillomavirusinfections[J].Eur J Cancer, 2002, 38: 2229-2242.
  • 8Melsheimer P, Vinokurova S,Wentzensen N, et al. DNA aneuploidyand integration of human papillomavirus type 16 e6/e7 oncogenes inintraepithelial neoplasia and invasive squamous cell carcinoma of thecervix uteri[J]. , Clin Cancer Res, 2004,10: 3059-3063.
  • 9Lansbury Jr P T. Inhibition of amyloid formation: a strategy to delaythe onset of Alzheimer's disease [J]Crrent Opinion in Chemical Bi-ology, 1997, 1(2): 260-267.
  • 10Ho G Y, Bierman R, Beardsley L, et al. Natural history of cervicov-aginal papillomavirus infection in young women [J].N Engl J Med,1998,38(7): 423-428.

二级参考文献17

  • 1吴家璐,李龙芸.荧光原位杂交技术对胸腔积液间期细胞染色体数目异常的研究[J].癌症进展,2005,3(5):467-470. 被引量:13
  • 2陶萍萍,卞美璐,李敏,刘军.HPV多重感染与宫颈病变关系探讨[J].中国妇产科临床杂志,2006,7(2):94-96. 被引量:112
  • 3Heseleyer-Haddad K, JanzV, Castle PE, et al. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia[J]. Am J Pathol,2003, 163(4) : 1405-1410.
  • 4Heselmeyer-Haddad K, Sommerfeld KM, White N, et al. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer [ J ]. Am J Pathol,2005, 166(4) : 1229-1238.
  • 5Lee C J, Suh E J, Kang HT, et aI. Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expressionin cell immortalized by HPV16-DNA [ J ]. Exp Cell Res,2002,277 ( 2 ) : 173-183.
  • 6Herrero R,Hildesheim A,Bratti C,et al.Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica[J].J Natl Cancer Inst,2000,92(6):464-474.
  • 7Cuzick J,Szarewski A,Terry G,et al.Human papillomavirus testing in primary cervical screening[J].Lancet,1995,345(8964):1533-1536.
  • 8Ho G Y,Bierman R,Beardsley L,et al.Natural history of cervicovaginal papillomavirus infection in young women[J].N Engl J Med,1998,338(7):423-428.
  • 9Gilbert G,Donders G,Gabrovska M,et al.Knowledge of cervix cancer,human papilloma virus(HPV)and HPV vaccination at the moment of introduction of the vaccine in women in Belgium[J].Arch Gynecol Obstet,2008,277(4):291-298.
  • 10Anttila A,Pukkala E.Effect of organized screening on cervical cancer incidence and mortality in Finland,1963~1995:Recent increase in cervical cancer incidence[J].Int J Cancer,1999,83(1):59-65.

共引文献25

同被引文献48

  • 1Jiabo Di,Tjitske Duiveman-de Boer,Carl G Figdor,Ruurd Torensma.Aiming to immune elimination of ovarian cancer stem cells[J].World Journal of Stem Cells,2013,5(4):149-162. 被引量:7
  • 2邬素芳,王薇,何福仙,马湘一,曾桂兰,郑红兵,徐茜,辜海念,杜娟,周利平,卢运萍,廖国宁,马丁.宫颈癌早期诊断4种方法的比较和意义[J].中国实用妇科与产科杂志,2004,20(10):612-614. 被引量:42
  • 3李艳红,张伟,朱少君,杨瑛,尹国武.早期宫颈癌筛查有效方案的探讨和研究[J].陕西医学杂志,2006,35(7):842-843. 被引量:25
  • 4宋丽君,魏波,李英勇.宫颈病变筛查方法的比较研究[J].检验医学,2007,22(2):139-141. 被引量:4
  • 5Kamiya Y, Shimada Y, Ito S, et al. Analysis of the quinolone-resis- tance determining region of the gyrA gene and the analogous region of the parC gene in Ureaplasma parvum and Ureaplasma urealyticum detected in first-void urine of men with non-gonocoecal urethritis [J]. J Antimicrob Chemother, 2013, 68(2): 480-482.
  • 6Grosso S, Bruschetta G, Camporese A. Experimental evaluation of the Sysmex UF- 1000i for ruling out non-gonococcal urethritis[J]. Infez Med, 2012, 20(3): 188-194.
  • 7Deguchi T, Ito S, Hagiwara N, et al. Antimicrobial chemotherapy of Mycoplasma genitalium-positive non-gonococcal urethritis [J]. Expert Rev Anti Infect Ther, 2012, 10(7): 791-803.
  • 8Ito S, Yasuda M, Seike K, et al. Clinical and microbiological out- comes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin[J]. J Infect Chemot- her, 2012, 18(3): 414-418.
  • 9Saunders JM, Hart G, Estcourt CS. Is asymptomatic non-chlamydial non-gonococcal urethritis associated with significant clinical conse- quences in men and their sexual partners: a systematic review[J]. Int J STD AIDS, 2011, 22(6): 338-341.
  • 10Kondrat'eva IuS, Ne?mark AI. Current approaches to the treatment of non-gonococcal urethritis in men[J]. Urologiia, 2011, (4): 32, 34-37.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部